NasdaqCM - Delayed Quote • USD
Aptose Biosciences Inc. (APTO)
At close: 4:00 PM EDT
After hours: 4:14 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 4 | 3 |
| Avg. Estimate | -0.74 | -0.65 | -4.27 | -2.72 |
| Low Estimate | -0.84 | -0.94 | -8.79 | -4.03 |
| High Estimate | -0.58 | -0.42 | -1.67 | -1.01 |
| Year Ago EPS | -2.25 | -2.27 | -7.58 | -4.27 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 3 |
| Avg. Estimate | -- | -- | -- | 510k |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 1.54M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -1.75 | -2.01 | -2.05 | -1.59 |
| EPS Actual | -2.25 | -2.27 | -1.76 | -1.44 |
| Difference | -0.5 | -0.26 | 0.29 | 0.15 |
| Surprise % | -28.60% | -12.90% | 14.10% | 9.40% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.74 | -0.65 | -4.27 | -2.72 |
| 7 Days Ago | -0.74 | -0.65 | -4.27 | -2.72 |
| 30 Days Ago | -0.88 | -0.72 | -5.11 | -3.07 |
| 60 Days Ago | -0.88 | -0.72 | -4.46 | -2.71 |
| 90 Days Ago | -1.6 | -1.76 | -5.46 | -2.71 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | 1 | 3 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | APTO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 67.10% | -- | -- | 1.60% |
| Next Qtr. | 71.40% | -- | -- | 10.50% |
| Current Year | 43.70% | -- | -- | 5.20% |
| Next Year | 36.30% | -- | -- | 13.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.22% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Related Tickers
BLPH Bellerophon Therapeutics, Inc.
0.0544
-4.73%
CGTX Cognition Therapeutics, Inc.
1.8400
0.00%
PRTC PureTech Health plc
26.15
-0.46%
ALRN Aileron Therapeutics, Inc.
4.7400
-5.20%
DSGN Design Therapeutics, Inc.
3.7000
-1.07%
BOLT Bolt Biotherapeutics, Inc.
1.1100
-2.63%
NGEN.V NervGen Pharma Corp.
2.2300
+11.50%
AKTX Akari Therapeutics, Plc
1.1662
-0.32%
ARTL Artelo Biosciences, Inc.
1.3150
+2.73%
APLM Apollomics, Inc.
0.4720
-7.45%